Result Summary for APV40005
| Protocol ID: | APV40005 |
| Clinical Study ID: | APV40005 |
| Official Title: | An open-label phase III study to provide access to fosamprenavir and to assess the long term safety and tolerability of fosamprenavir containing regimens in HIV Infected patients with limited treatment options |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | Telzer,Telzir,Lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
